(Q36243099)

13 August 2017

1 reference

title

NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate (English)

1 reference

13 August 2017

Kevin Crofton

3

0 references

author name string

Mari Golub

1

1 reference

13 August 2017

Lucio Costa

2

1 reference

13 August 2017

Deborah Frank

4

1 reference

13 August 2017

Peter Fried

5

1 reference

13 August 2017

Beth Gladen

6

1 reference

13 August 2017

Rogene Henderson

7

1 reference

13 August 2017

Erica Liebelt

8

1 reference

13 August 2017

Shari Lusskin

9

1 reference

13 August 2017

Sue Marty

10

1 reference

13 August 2017

Andrew Rowland

11

1 reference

13 August 2017

John Scialli

12

1 reference

13 August 2017

Mary Vore

13

1 reference

13 August 2017

publication date

1 August 2005

1 reference

Birth Defects Research Part B: Developmental and Reproductive Toxicology

13 August 2017

published in

1 reference

13 August 2017

volume

74

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

300-381

1 reference

Childhood chemotherapy and later drug abuse and growth curve: a follow-up study of 30 adolescents

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Intravenous pentazocine and methylphenidate abuse during pregnancy. Maternal lifestyle and infant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Pharmacokinetics of methylphenidate in hyperkinetic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Methylphenidate and growth in hyperactive children. A controlled withdrawal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Slowing of growth in height and weight on stimulants: a characteristic pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

One-year follow-up of hyperactive boys treated with imipramine or methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Growth of Hyperactive Children Treated With Methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

d-Methylphenidate is non-genotoxic in in vitro and in vivo assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRB.20049

21 January 2018

Identifiers

DOI

10.1002/BDRB.20049

1 reference

13 August 2017

1 reference